• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
  • 18 Jan 17
title

New admissions outperform AIM

  • 1727 views
James Valentine

Digital editor at Research Tree

 
Hotel Chocolat IPO
Strap line

Lower numbers of new issues has raised standard of companies coming to AIM

Companies: ADGRF, AFG, PRSM, ECP, MYE0


Body

 

An extract from Northland Capital's AIM Journal - January


New admissions outperform AIM

Lower numbers of new issues has meant the standard of the companies coming to AIM has been higher

 

There has been a focus on the lower number of new admissions on AIM in the past few years and a consequence of this has been the reduction in the number of companies on the junior market. This is perceived to be a negative by many but in reality it is not. The lower number of admissions has led to a higher quality threshold for flotations.

 

Although the market has performed strongly in each of the past two years, a limited number of companies have floated on AIM. There were 61 new entrants in 2015 and the number reached 64 in 2016 – still a relatively modest figure. However, the £1.1bn raised by new entrants in 2016 was lower than the £1.24bn raised in 2015. The money raised by existing companies was also lower than the £4.22bn raised in 2015, even though Sirius Minerals, alone, raised £370.2m.

 

December was not as active a month as had been expected. In fact, it was one of the least active Decembers in the current decade despite the early promise. US-focused oil and gas producer Diversified Gas & Oil, which has debentures quoted on Nex Exchange (ISDX), has delayed its flotation to January. It was set to raise $60m from an ordinary share issue on AIM, in order to pay of the debentures and fund further acquisitions, but this figure has been reduced to $40m.

 

Mongolia-focused property investor and cement manufacturer Asia Pacific Investment Partners also failed to join AIM before the end of December. These two companies would have pushed the amount raised by new admissions nearer to 2015 levels.

 

The number of UK-based flotations has increased, while international entrants has declined to the lowest level since 2009 when there were six international companies out of 36 new admissions. In 2016, though, international companies made up less than one-seventh of the total. This indicates that there is an increasing focus on UK businesses as Chinese companies in particular have fallen out of favour.

 

It should be noted, though, that some international companies float via a UK holding company so it is di cult to assess how many international companies have joined.

 

Flood


There were 982 companies, including readmissions, which joined AIM in 2005 and 2006. By coincidence that is the same number of AIM companies still on the market at the end of 2016.

 

While that level of new admissions makes great headlines, it rarely makes for good investments. Water is a good thing but a flood does no one any favours. There were good companies but the long-term perspective has been overshadowed by the food of companies that have done little or failed. This view still dominates the perception of AIM in many people’s minds, particularly rival exchanges that want to undermine AIM.

 

Even initially, the performance of most of these companies was not good.

 

Quality

 

Contrast that with the performance, at least in the short term, of the new entrants in the past two years. In 2015, the average gain of new entrants from admission was 12.7%, with a roughly even split of companies where the share price rose and those where it fell. The median rise was 4.1%.

 

In 2016, the vast majority of the new entrants had a higher share price at the end of the year.

 

AIM broker Stockdale Securities has published figures for the new entrants, excluding readmissions, and the performance was even better than in 2015. Stockdale identified 38 companies and seven of those fell, with the rest making gains.

 

Italy-based renewable power generator Cogenpower was more than 40% lower due to poor trading and changes in its strategy but most of the others were a few percentage points lower. In 2015, there were companies where the share price had slumped by 50% or more, including online media firm Adgorithms and China-based fish supplier Aquatic Food.

 

Interestingly, three out of the ten largest companies floating ended the year with a lower share price. It might have been thought that the larger companies should have a stronger

base and the downside risk would be lower. Most of the best performers had a market capitalisation of less than £50m.

 

The best-performing new entrant in 2016 was software robotics company Blue Prism, which was 470% ahead at the end of the year. Stockdale excludes this from its calculation and it still comes up with an average gain of 42%. The other strong performers include Franchise Brands, MaxCyte Inc, the winner of the AIM best technology award, and Hotel Chocolat.

 

There has certainly not been a drought when it comes to new admissions. In fact, there has been more fertile material.

 

AIM was 14% higher in 2016 but it was significantly outperformed by the new entrants. It should be noted, though, that the index is weighted by market capitalisation whereas the performance of new entrants does not take size into account. Hopefully, the quality of new companies will remain high even if this limits the number of flotations.

 


Body Two

Body Three

Body Four

Body Five

The information contained within this post is based on personal experience and opinion and should not be considered as a recommendation to trade nor financial advice.

More Content

More Content

PANMURE LIBERUM: Prescribed reading: Recovery despite uncertainty

Companies: GNS FDBK AMS SN/ EKF EAH ANCR FUM TSTL HIK CVSG SCLP COG HVO CTEC OXB DXRX NIOX SPI IHC AVCT HCM OHGR AREC MXCT ONT OPT

Panmure Liberum

MaxCyte increases dose level for mesothelioma and ovarian cancer patients in its Phase I trials

Companies: MaxCyte, Inc.

Proactive

PANMURE LIBERUM: Prescribed reading: A Trump in the road ?

Companies: KOO MYE0 GNS FDBK AMS SN/ EKF ANCR FUM TSTL HIK CVSG SCLP COG HVO CTEC OXB DXRX NIOX SPI IHC AVCT HCM OHGR AREC OPT

Panmure Liberum

MaxCyte appoints life-sciences vet as EVP, updates on lead therapy to treat solid tumors

Companies: MaxCyte, Inc.

Proactive

PANMURE LIBERUM: Pharma Services Recovery?: ...and then there was Trump

Companies: MYE0 EKF HIK COG HVO OXB DXRX AREC

Panmure Liberum
next
 
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In